S25 by the C/EBPb dificiency in the chondrocytes. p57 was co-localized with C/EBPb in late proliferative and pre-hypertrophic chondrocytes of the growth plate, which was dramatically decreased by the C/EBPb deficiency. The promoter activity of p57 was enhanced by C/EBPb transfection. Deletion, mutagenesis, and tandem-repeat analyses of the luciferase assay identified the core responsive element to be between the −150 and −130 bp region containing a putative C/EBP-binding motif. EMSA revealed the binding of C/EBPb-overexpressed nuclear extracts with the oligonucleotide including this region, whose specificity was verified by the C/EBPb antibody supershift. The knockdown of p57 by the siRNA inhibited the C/EBPb-induced hypertrophic differentiation in cultured chondrocytes. Conclusions: C/EBPb directly transactivates p57 at a specific C/EBP motif to promote transition from proliferation to hypertrophic differentiation of chondrocytes during skeletal growth, indicating the essential role of the C/EBPb/p57 signal during endochondral ossification.
Purpose: Mitochondria are involved in many cellular processes, and mitochondrial dysfunctions have been associated with apoptosis, aging and a number of pathological conditions, including osteoarthritis (OA). Therefore, mitochondrial proteins are an attractive target to study the metabolism of chondrocyte and its role in cartilage degradation. We aimed in this work to analyze the mitochondrial protein changes that are characteristic of OA chondrocytes, and identify a new OA-related mitochondrial protein profile. Methods: Chondrocytes were obtained from OA patients undergoing joint replacement, and cartilages from autopsies without history of joint disease. Mitochondria were isolated by differential centrifugation processes. Protein profiling was carried out using the differential in-gel electrophoresis technology (DIGE). Briefly, mitochondrial proteins from control and OA samples were labelled with different fluorescent dyes and co-resolved by 2D gel electrophoresis using a pool of all samples as internal standard. Biological variation analysis, statistics and hierarchical clustering were performed using DeCyder software. OA-related proteins were identified by MALDI-TOF/TOF mass spectrometry. Validation of the results was carried out by real-time PCR, Western blotting and immunofluorescence analyses. Pathway analysis was performed using PathwayStudio software. Results: We examined more than 1500 protein spots that were present in the six different DIGE gels. Both qualitative and quantitative changes in protein abundance patterns were studied, considering changes within 95% confidence interval and standardized average ratios exceeding 1.3 in at least four of the six analyzed gels. 28 protein spots were found to be increased in OA cells, including the TNFa-receptor-associated protein and two subunits of the mitochondrial respiratory chain complex I. On the other hand, 45 protein spots were decreased in OA chondrocytes, including two mitofilin and two mitochondrial superoxide dismutase (MnSOD, ratio −1.6, p = 0.0024) forms. Unsupervised Principal Component Analysis and hierarchical clustering (HCA) of these 73 differentially present proteins -22 of them which were previously defined as mitochondrial ( Figure 1 ) -allowed the definition of two different protein profiles corresponding to OA and control samples. Network analysis was accomplished to evaluate the biological functions affected by this chondrocyte mitochondrial dysregulation in OA. Validation of the results was performed for MnSOD by western blot and real time PCR on OA and normal chondrocyte protein extracts. We also found MnSOD protein levels significantly decreased in osteoarthritic cartilage superficial layer when compared to control. Conclusions: This study describes the differences between the mitochondrial protein profiles of normal and OA chondrocytes, evidencing the mitochondrial dysregulation that takes place during cartilage degradation in osteoarthritis. Reduction of MnSOD in OA chondrocytes suggests a decreased antioxidant activity of cartilage cells that might contribute to tissue degradation. Purpose: Evidence suggests that cell aging or senescence is important in the pathogenesis of osteoarthritis (OA). Indeed, by analogy to neurodegenerative disorders, OA has been termed by Aigner as the "M. Alzheimer" of articular cartilage. In certain forms of progeria, a defect in lamin A processing leads to accelerated aging of mesenchymal tissues, and development of OA at a very young age. In the current study, we report that OA chondrocytes accumulate lamin A, leading to activation of caspase 3 and mitochondrial dysfunction. Methods: Human OA cartilage samples and chondrocytes were isolated from patients undergoing knee replacement surgery as approved by IRB. Standard Western Blot, fluorescent microscopy, and Q-PCR techniques were used. Anti-human lamin A antibody was purchased from Abcam Inc. TUNEL staining (Roche), ATP Bioluminescence assays (Sigma), and activated caspase 3 assays (R&D) were performed per manufacturer's recommendations. Results: Lamin A expression was markedly increased (immuno blot) in chondrocytes derived from OA cartilage samples (n = 6) when compared with age matched healthy controls (n = 4). Q-PCR analysis demonstrated a significant increase in the Lamin A: Lamin B mRNA ratio in the OA samples (2.9±0.4 in healthy controls vs. 7.2±1.7 in OA subjects). Since Il-1b and PGE 2 are catabolic mediators, which have been shown to promote apoptosis in OA chondrocytes, we explored their effects on lamin A expression. Il-1b caused little to no change in lamin A expression. In contrast the exposure of chondrocytes to PGE 2 (10 uM) caused a marked increased lamin A accumulation (Western blot) in a rimmed pattern around the nucleus (confocal microscopy), as well as an increase in lamin A:lamin B mRNA ration (Q-PCR). This pattern of increased protein expression and lamin A:lamin B mRNA mimicked that observed in OA cartilage, suggesting that PGE 2 augments lamin A expression via posttranslational mechanisms. These effects by exogenous PGE2 on lamin A expression were blocked by antagonists of the EP2 receptor, but not
